跳至主要内容
临床试验/NCT07009769
NCT07009769已完成不适用

Retrospective Clinical Study for Developing an AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy

Korea University Guro Hospital1 个研究点 分布在 1 个国家目标入组 865 人开始时间: 2024年10月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
865
试验地点
1
主要终点
Diagnostic accuracy of the AI-based classification model using SERS signals from plasma-derived exosomes

研究概览

简要总结

The investigators aim to develop an AI-powered precision medicine system based on liquid biopsy that can comprehensively provide lung cancer patients with information on disease stage, histologic subtype, and presence of genetic mutations.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Diagnostic accuracy of the AI-based classification model using SERS signals from plasma-derived exosomes

时间窗: Retrospective, based on pre-collected samples through study completion, an average of 1 year

To evaluate the diagnostic performance (sensitivity, specificity, and overall accuracy) of a machine learning model trained on SERS spectral data of plasma-derived exosomes in distinguishing lung cancer patients from healthy controls.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hyun Koo Kim

Professor

Korea University Guro Hospital

研究点 (1)

Loading locations...

相似试验